Medigen Biotechnology Corp. (TPEX: 3176)
35.80
+0.10 (0.28%)
Sep 11, 2024, 11:26 AM CST
Medigen Biotechnology Revenue
Medigen Biotechnology had revenue of 354.11M TWD in the quarter ending June 30, 2024, with 72.26% growth. This brings the company's revenue in the last twelve months to 1.39B, up 85.91% year-over-year. In the year 2023, Medigen Biotechnology had annual revenue of 1.16B with 9.64% growth.
Revenue (ttm)
1.39B
Revenue Growth
+85.91%
P/S Ratio
3.57
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.16B | 101.77M | 9.64% |
Dec 31, 2022 | 1.06B | -2.87B | -73.08% |
Dec 31, 2021 | 3.92B | 3.31B | 537.17% |
Dec 31, 2020 | 615.54M | 63.20M | 11.44% |
Dec 31, 2019 | 552.35M | 145.04M | 35.61% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition